 CLEVELAND-- BUSINESS WIRE --Athersys, Inc. Nasdaq: ATHX, a regenerative medicine company developing MultiStem invimestrocel for critical care indications, announced today its participation in two November conferences, the Challenges and Opportunities for Mesenchymal Stem Cells digital conference being held November 17-18, 2022 and A.G.P.s Biotech Conference on November 30, 2022. 